Nutrien (NYSE:NTR) Price Target Raised to $70.00 at Barclays

Nutrien (NYSE:NTRFree Report) had its target price lifted by Barclays from $64.00 to $70.00 in a research report report published on Wednesday morning,Benzinga reports. The brokerage currently has an equal weight rating on the stock.

Several other research firms have also commented on NTR. Weiss Ratings reissued a “hold (c)” rating on shares of Nutrien in a research note on Monday, December 29th. Oppenheimer reissued an “outperform” rating on shares of Nutrien in a research report on Tuesday, January 27th. Royal Bank Of Canada raised their price objective on Nutrien from $70.00 to $75.00 and gave the company an “outperform” rating in a research report on Tuesday, January 20th. Scotiabank lifted their price objective on Nutrien from $63.00 to $70.00 and gave the company a “sector perform” rating in a research note on Monday, February 2nd. Finally, Mizuho increased their target price on Nutrien from $65.00 to $68.00 and gave the stock a “neutral” rating in a research note on Friday, January 16th. Two equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $66.69.

Read Our Latest Stock Report on Nutrien

Nutrien Price Performance

Shares of NTR stock opened at $70.37 on Wednesday. The stock has a market cap of $33.88 billion, a price-to-earnings ratio of 18.97 and a beta of 0.73. The business’s fifty day moving average is $65.84 and its 200 day moving average is $60.49. Nutrien has a twelve month low of $45.78 and a twelve month high of $73.55. The company has a quick ratio of 0.89, a current ratio of 1.41 and a debt-to-equity ratio of 0.39.

Nutrien (NYSE:NTRGet Free Report) last announced its earnings results on Wednesday, February 18th. The company reported $0.83 EPS for the quarter, missing analysts’ consensus estimates of $0.87 by ($0.04). The business had revenue of $5.12 billion for the quarter, compared to the consensus estimate of $5.26 billion. Nutrien had a net margin of 6.79% and a return on equity of 7.54%. The business’s quarterly revenue was up 5.1% on a year-over-year basis. During the same quarter last year, the firm posted $0.31 EPS. Research analysts expect that Nutrien will post 3.72 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Metis Global Partners LLC boosted its holdings in Nutrien by 37.8% in the 3rd quarter. Metis Global Partners LLC now owns 220,648 shares of the company’s stock worth $12,958,000 after buying an additional 60,491 shares during the period. Campbell & CO Investment Adviser LLC lifted its position in shares of Nutrien by 122.1% in the third quarter. Campbell & CO Investment Adviser LLC now owns 68,124 shares of the company’s stock valued at $4,000,000 after acquiring an additional 37,447 shares in the last quarter. Advisors Asset Management Inc. lifted its position in shares of Nutrien by 20.2% in the second quarter. Advisors Asset Management Inc. now owns 69,551 shares of the company’s stock valued at $4,051,000 after acquiring an additional 11,704 shares in the last quarter. Sagard Holdings Management Inc. bought a new position in shares of Nutrien in the second quarter worth about $1,511,000. Finally, Colrain Capital LLC grew its position in shares of Nutrien by 35.6% during the third quarter. Colrain Capital LLC now owns 128,150 shares of the company’s stock worth $7,595,000 after purchasing an additional 33,650 shares in the last quarter. 63.10% of the stock is owned by institutional investors.

Key Stories Impacting Nutrien

Here are the key news stories impacting Nutrien this week:

  • Positive Sentiment: Board boosts shareholder returns — Nutrien raised its quarterly dividend to US$0.55 and announced intent to repurchase up to 5% of outstanding shares, which supports cash return to shareholders and can be accretive to EPS. Nutrien Increases Quarterly Dividend and Announces Intent to Launch a New Share Repurchase Program
  • Positive Sentiment: Strong 2025 operating results and guidance tone — Company-released results show solid adjusted EBITDA and management described 2025 as a “defining year” with cost and capex reductions exceeding targets; the release included full-year 2025 results and 2026 guidance (supportive for near-term outlook). Nutrien Reports Full-Year 2025 Results and Provides 2026 Guidance
  • Neutral Sentiment: Analyst target/coverage updates mixed but not overtly bullish — Barclays raised its price target to $70 with an “equal weight” rating (close to current levels), which is more of a neutral datapoint than a buy signal. Barclays Raises Price Target
  • Neutral Sentiment: UBS assigns a “hold” — another neutral/benchmarked view from the street that suggests no strong analyst consensus upgrade pressure. Nutrien Gets a Hold from UBS
  • Negative Sentiment: Quarterly EPS missed some estimates — Adjusted earnings per share was reported around $0.83 (company Zacks/BusinessWire figure) but missed certain consensus figures (~$0.87); other outlets reported a $0.76 EPS print vs. estimates. A miss on adjusted EPS can temper investor enthusiasm despite underlying cash metrics. Nutrien (NTR) Q4 Earnings Lag Estimates MarketBeat Q4 Summary
  • Negative Sentiment: Mixed/more negative third‑party summaries — Some data summaries (QuiverQuant) flagged large year-over-year declines in revenue and margins in certain line items and reported an initial post-close share dip, highlighting how headline metrics can be interpreted negatively by traders. Nutrien Ltd. (NTR) Stock Falls on Q4 2025 Earnings

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Featured Stories

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.